000627 Hubei Biocause Pharmaceutical
- 5.07
- +0.21+4.32%
Hubei Biocause Pharmaceutical News
Tianmao Group: Report for the third quarter of 2024
Tianmao Group: Tianmao Group\'s performance forecast for the first three quarters of 2024
Tianmao Group: Guohua Life 2024 Semi-Annual Report
Tianmao Group: 2024 Semi-Annual Report Summary
Tianmao Group: 2024 Semi-Annual Report
Hubei Biocause Pharmaceutical: 2024-043- Hubei Biocause Pharmaceutical's half-year performance forecast for 2024.
Hubei Biocause Pharmaceutical: 2024 First Quarter Report
Hubei Biocause Pharmaceutical: 2023 Annual Report Summary
Hubei Biocause Pharmaceutical: 2023 ANNUAL REPORT
Tianmao Group: Tianmao Group\'s performance forecast for the first quarter of 2024
Tianmao Group: Tianmao Group 2023 Annual Results Report
Tianmao Group: 2024-008-Tianmao Group 2023 Annual Results Forecast
Tianmao Group: Report for the third quarter of 2023
Tianmao Group: Tianmao Group\'s performance forecast for the first three quarters of 2023
Tianmao Group: Semi-Annual Report 2023
Tianmao Group: Summary of the 2023 Semi-Annual Report
Tianmao Group: Tianmao Group\'s 2023 semi-annual results forecast
Tianmao Group: Report for the first quarter of 2023
Tianmao Group: 2022 Annual Report
Tianmao Group: 2022 Annual Report Summary
No Data
